"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"
Conditions
- Colitis, Ulcerative
- Crohn's Disease
Interventions
- DRUG: Infliximab-Biosimilar
- DRUG: Infliximab-Innovator
Sponsor
Onze Lieve Vrouwe Gasthuis
Collaborators